We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SGM:ASXSims Ltd. Analysis

Data as of 2026-06-21 - not real-time

A$29.20

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Sims Limited is trading firmly above its 20‑day and 50‑day moving averages (around 27.5 and 23.7 AUD) with a bullish MACD crossover and a rising volume trend, indicating short‑term momentum. However, the RSI is perched near 70, suggesting the stock may be edging into overbought territory and could face a near‑term pullback toward the identified support around 23.0 AUD. Fundamentally, the company posted a modest revenue growth of 3.5% but remains loss‑making with a negative profit margin and a free‑cash‑flow deficit, even though forward earnings estimates turn positive and the forward PE sits near 16. The dividend yield of just under 1% is supported by a low payout ratio, but sustainability is questionable given the current earnings profile. Analyst consensus is neutral with a “hold” rating and median target near 31 AUD, aligning the market price of 29.2 AUD close to fair value while the sector’s cyclical nature and high 30‑day volatility (~33%) add risk.
Overall, the stock presents a blend of value and growth characteristics: technical strength and modest upside potential are tempered by earnings volatility, debt levels, and sector‑specific regulatory pressures. Investors should monitor earnings releases for signs of a sustained turnaround and watch the price action around the key resistance level near 31.8 AUD before committing to larger positions.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI approaching overbought levels
  • Proximity to resistance at ~31.8 AUD
  • Increasing volume supporting current trend

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward EPS turning positive
  • Analyst median price target around 31 AUD
  • Bullish technical setup with SMA alignment

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Potential earnings turnaround and cash‑flow improvement
  • Diversified geographic footprint reducing single‑market exposure
  • Modest dividend yield with low payout ratio offering upside if profitability stabilises

Key Metrics & Analysis

Financial Health

Revenue Growth3.50%
Profit Margin-0.76%
P/E Ratio15.8
ROE-2.23%
ROA-0.51%
Debt/Equity29.03
P/B Ratio2.3
Op. Cash FlowA$104.5M
Free Cash FlowA$-45325000

Technical Analysis

TrendBullish
RSI69.3
SupportA$23.05
ResistanceA$31.81
MA 20A$27.47
MA 50A$23.68
MA 200A$19.04
MACDBullish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

Fair ValueA$2.70
Target PriceA$28.98
Upside/Downside-0.75%
GradeFair
TypeBlend
Dividend Yield0.92%

Risk Assessment

Beta0.77
Volatility32.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.